Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This is a combination of three B-vitamins (B6, B12, and folate) used as a therapeutic intervention to lower plasma homocysteine levels. In the context of the Brigham and Women's Hospital pilot study, it was evaluated as part of a multi-drug regimen (including pravastatin, aspirin, and ramipril) to prevent accelerated atherosclerosis in patients with Systemic Lupus Erythematosus (SLE). Elevated homocysteine is an independent risk factor for cardiovascular disease, and these vitamins serve as essential cofactors in the metabolic pathways that convert homocysteine to methionine or cysteine.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on pyridoxine + cyanocobalamin + folic acid.